The baby oil generation is now the skin cancer generation. Non-melanoma skin cancer, or pre-cancer, is the #1 cancer in the Western world, with nearly 100 million cases annually, most untreated. Innovation in skin cancer treatment has stagnated for over 60 years, with Efudex, a 70-year-old cytotoxic drug, still the standard, causing significant pain and side effects.

InnoPath Therapeutics is revolutionizing treatment with first- and best-in-class topical therapeutics for Actinic Keratosis and Non-Melanoma Skin Cancer.